Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

CYTR:US

3.2800 USD 0.0700 2.09%

As of 20:10:00 ET on 03/27/2015.

Snapshot for CytRx Corp (CYTR)

Open: 3.3400 Day's Range: 3.2500 - 3.4200 Volume: 519,928
Previous Close: 3.3500 52wk Range: 2.0800 - 5.4600 1-Yr Rtn: -4.37%

Stock Chart for CYTR

No chart data available.
  • CYTR:US 3.2800
  • 1D
  • 1M
  • 1Y
3.3500
Interactive CYTR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CYTR

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.5500
Est. EPS (USD) (12/2015) -0.9150
Est. PEG Ratio -
Market Cap (M USD) 182.77
Shares Outstanding (M) 55.72
30 Day Average Volume 691,596
Price/Book (mrq) 2.7009
Price/Sale (ttm) 1,771.7441
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/01/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CYTR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CYTR

CytRx Corporation is a biopharmaceutical research and development company. The Company focuses in the development of high-value human therapeutics, specializing in oncology. CytRx is also developing two drug candidates based on its molecular chaperone regulation technology.

Steven A KriegsmanPresident/CEOJean-Yves Caloz "John"CFO/Treasurer
Joseph RubinfeldChief Scientific AdvisorBenjamin S LevinSenior VP/Gen Counsel/Secretary
More Company Profile & Key Executives for CYTR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil